RavenQuest Signs Services Contract With Alexander First Nation

VANCOUVER, British Columbia, Aug. 15, 2018– RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) is pleased to announce it has entered into a services agreement with Alexander First Nation to develop a Health Canada cannabis license application. Alexander First Nation is located adjacent to the Edmonton Metropolitan Region and plans to build a cannabis facility on its sovereign land.

“We are genuinely excited to be working with Alexander First Nation,” stated George Robinson, CEO of RavenQuest. “Today’s announcement marks the beginning of a trusting and mutually beneficial relationship. We’ve taken a huge first step toward a brighter economic future for both Alexander First Nation and RavenQuest,” said Robinson.

“This agreement speaks to our continued commitment to working with Indigenous communities,” Robinson continued. “We see the economic and social impact these partnerships can bring and will continue our work in earnest to establish similar partnerships and engagements with unique Indigenous communities in the months ahead.”

About RavenQuest BioMed Inc.

RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.

The Company focuses on partnerships with Indigenous communities and entered into an MOU to construct a cannabis production facility on sovereign land of Fort McMurray First Nation #468. RavenQuest has also recently entered into an LOI to pursue the acquisition of Western Agripharma Ltd., a late stage application with a production facility under construction on British Columbia’s sunshine coast.

On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.

“George Robinson”
Chief Executive Officer

For further information, please contact:
Mathieu McDonald, Corporate Communications 604-484-1230

NT5